[PP.08.21] RELATIONSHIP OF METABOLIC SYNDROME AND RISK OF DEVELOPING CARDIOVASCULAR DISEASE AND DIABETES FOR POPULATION OF Kazakhstan

2017

Closed access Metadata (CSL-JSON)
DOI 10.1097/01.hjh.0000523398.42463.1f
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Objective: Metabolic syndrome (MS) is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. Some studies have examined the relationship between MS and psychological risk factors such as depression, anxiety, tension, current perceived stress and anger. We researched risks of cardiovascular diseases, diabetes, the prevalence of states of anxiety and depression among Central Kazakhstan's population with MS. Design and method: 3683 Central Kazakhstan citizens (2829 women and 854 men) aged 18 to 65 (45 ± 12,71 (M ± Std.Dev)) were examined. 543 people were diagnosed with metabolic syndrome which accounted for 14,74% (CI: 13,61; 15,93). SCORE, FINDRISK charts were used to evaluate risks. PHQ-9 and GAD-7scales were used to determine levels of depression and anxiety. Results: Most important differences were determined for the prevalence of diabetes and cardiovascular disease risks. Clearly increased risk for diabetes was found for 19,7% (CI 16,34; 23,06) of people with MS, almost 80,46% (CI 77,11; 83,81) had high risk of cardiovascular disorders. Depression states were common among people with MS - almost 25% of examined had moderate, moderately severe or severe depressions. Severe anxiety level was observed for 18,05% (CI 14,8; 21,3). Among women, diabetes risks were more pronounced, whereas for men it were cardiovascular risks. Severe anxiety was observed more frequently among women than among men (19,27% (CI 15,57; 22,97) and 12,75% (CI 6,28; 19,22) respectively). However, almost 9% of men and 5,5% of women had moderately severe and severe depressions. Conclusions: The prevalence of metabolic syndrome in Central Kazakhstan is significantly lower than in Europe or the U.S. However, as is the case for other countries, high risk of development of diabetes and cardiovascular disorders are observed among people with MS. Gathered results confirm the role of anxiety and depression conditions in MS development.